Suppr超能文献

结节病成人患者的住院原因及全因死亡率

Reasons for Hospitalization and All-Cause Mortality for Adults with Sarcoidosis.

作者信息

Manansala Michael, Sami Faria, Arora Shilpa, Manadan Augustine M

机构信息

Division of Rheumatology, Rush University Medical Center, Chicago, Ill.

Department of Internal Medicine, Cook County Health, Chicago, Ill.

出版信息

Am J Med Open. 2023 Feb 24;9:100037. doi: 10.1016/j.ajmo.2023.100037. eCollection 2023 Jun.

Abstract

PURPOSE

Sarcoidosis is a multisystem immune disease with a high rate of hospitalization. There is a paucity of large population-based studies on sarcoid inpatients. We aimed to examine the reasons for hospitalizations and mortality of adult sarcoid patients utilizing the National Inpatient Sample (NIS) database.

METHODS

Adult hospitalizations in 2016-2019 NIS database with sarcoidosis (ICD-10 code D86) were analyzed. The "reason for hospitalization" and "reason for in-hospital death" were divided into 19 organ system/disease categories based on their principal ICD-10 hospital billing diagnosis.

RESULTS

Among the 330,470 sarcoid hospitalizations, cardiovascular (20.4%) and respiratory (16.9%) diagnoses were the most common reasons for hospitalization. The most common individual diagnoses were sepsis and pneumonia. In-hospital death occurred in 2.4% of sarcoid hospitalizations. The most common reasons for death were infectious (30%), cardiovascular (20.7%), and respiratory (20.3%) diagnoses. The most common individual diagnoses in the deceased group were sepsis and respiratory failure. Finally, the sarcoid group had a higher frequency of complications including arrhythmias/heart blocks, heart failure, cranial neuropathies, hypercalcemia, iridocyclitis, myocarditis, and myositis. Sarcoid inpatients had longer length of stay (4 vs 3 days; < .001) and higher median total hospital charges ($36,865 vs $31,742; < .001).

CONCLUSIONS

The most common reasons for sarcoid hospitalizations were cardiovascular and respiratory. Nearly 1 in 40 hospitalizations resulted in death, with most common complications being conduction abnormalities and heart failure. The most common causes of in-hospital death were sepsis and respiratory failure. Sarcoid hospitalizations had 16% higher total hospital charges compared to nonsarcoid inpatients.

摘要

目的

结节病是一种多系统免疫疾病,住院率较高。目前缺乏基于大量人群的结节病住院患者研究。我们旨在利用国家住院样本(NIS)数据库研究成年结节病患者的住院原因和死亡率。

方法

分析2016 - 2019年NIS数据库中诊断为结节病(ICD - 10编码D86)的成年住院患者。根据其主要的ICD - 10医院计费诊断,将“住院原因”和“院内死亡原因”分为19个器官系统/疾病类别。

结果

在330470例结节病住院病例中,心血管(20.4%)和呼吸系统(16.9%)诊断是最常见的住院原因。最常见的个体诊断是脓毒症和肺炎。2.4%的结节病住院患者发生院内死亡。最常见的死亡原因是感染性(30%)、心血管(20.7%)和呼吸系统(20.3%)诊断。死亡组最常见的个体诊断是脓毒症和呼吸衰竭。最后,结节病组并发症发生率较高,包括心律失常/心脏传导阻滞、心力衰竭、颅神经病变、高钙血症、虹膜睫状体炎、心肌炎和肌炎。结节病住院患者住院时间更长(4天对3天;P <.001),总住院费用中位数更高(36865美元对31742美元;P <.001)。

结论

结节病住院最常见的原因是心血管和呼吸系统疾病。近40例住院患者中有1例死亡,最常见的并发症是传导异常和心力衰竭。院内死亡最常见的原因是脓毒症和呼吸衰竭。与非结节病住院患者相比,结节病住院患者的总住院费用高16%。

相似文献

1
Reasons for Hospitalization and All-Cause Mortality for Adults with Sarcoidosis.
Am J Med Open. 2023 Feb 24;9:100037. doi: 10.1016/j.ajmo.2023.100037. eCollection 2023 Jun.
3
Reasons for Hospitalization and In-Hospital Mortality in Adult Systemic Lupus Erythematosus.
ACR Open Rheumatol. 2020 Nov;2(11):683-689. doi: 10.1002/acr2.11195. Epub 2020 Nov 8.
4
Reasons for Hospitalization and In-Hospital Mortality in Adults With Dermatomyositis and Polymyositis.
J Clin Rheumatol. 2022 Mar 1;28(2):e433-e439. doi: 10.1097/RHU.0000000000001754.
5
Reasons for hospitalization and in-hospital mortality in adults with systemic sclerosis: Analysis of the National Inpatient Sample.
J Scleroderma Relat Disord. 2022 Oct;7(3):189-196. doi: 10.1177/23971983221083225. Epub 2022 May 11.
7
An Analysis of Rheumatoid Arthritis Hospitalizations.
Cureus. 2020 Dec 28;12(12):e12344. doi: 10.7759/cureus.12344.
8
The burden of cardiac arrhythmias in sarcoidosis: a population-based inpatient analysis.
Ann Transl Med. 2018 Sep;6(17):330. doi: 10.21037/atm.2018.07.33.
9
All-cause hospitalizations and mortality in systemic lupus erythematosus in the US: results from a national inpatient database.
Rheumatol Int. 2020 Mar;40(3):393-397. doi: 10.1007/s00296-019-04484-5. Epub 2019 Nov 26.

本文引用的文献

1
Comorbidities of sarcoidosis.
Ann Med. 2022 Dec;54(1):1014-1035. doi: 10.1080/07853890.2022.2063375.
2
Sarcoidosis and increased risk of comorbidities and mortality in sweden.
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):104-135. doi: 10.36141/svdld.v37i2.9142. Epub 2020 Jun 30.
3
The incidence, comorbidity and mortality of sarcoidosis in Korea, 2008-2015: a nationwide population-based study.
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(1):24-26. doi: 10.36141/svdld.v37i1.7660. Epub 2020 Mar 15.
4
Sarcoidosis Epidemiology: Race Matters.
Front Immunol. 2020 Sep 15;11:537382. doi: 10.3389/fimmu.2020.537382. eCollection 2020.
5
Predictors of mortality in fibrosing pulmonary sarcoidosis.
Respir Med. 2020 Aug;169:105997. doi: 10.1016/j.rmed.2020.105997. Epub 2020 May 12.
6
Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study.
Eur Respir J. 2020 Sep 3;56(3). doi: 10.1183/13993003.00767-2020. Print 2020 Sep.
8
Economic burden of sarcoidosis in a commercially-insured population in the United States.
J Med Econ. 2017 Oct;20(10):1048-1055. doi: 10.1080/13696998.2017.1351371. Epub 2017 Jul 21.
10
Sarcoidosis Increases Risk of Hospitalized Infection. A Population-based Study, 1976-2013.
Ann Am Thorac Soc. 2017 May;14(5):676-681. doi: 10.1513/AnnalsATS.201610-750OC.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验